|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00557 TIANYUAN HEALTH
Nominal 
0.510 0.000 (0.000%) | 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/12 HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | |
| Turnover | 20,047 | 137.636% | 19,178 | 26,845 | 45,230 | 54,216 |
| Cost of Sales | (2,988) | 886.139% | (2,939) | (5,607) | (17,285) | (19,391) |
| Gross Profit | 17,059 | 109.750% | 16,239 | 21,238 | 27,945 | 34,825 |
| 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/12 HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | (27,248) | (23,473) | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | 2,744 | 2,497 | (10,013) | (800) | |
| Share of Results of Asso. & JCEs | (56) | -47.170% | (311) | (14) | (365) | 242 | |
| Profit / (Loss) before Taxation | 1,691 | -- | (39,066) | (38,429) | (28,778) | (40,349) | |
| Taxation | 0 | -- | 650 | (177) | 1,821 | 0 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 2,509 | 1.456% | 4,402 | 4,368 | 11,473 | 11,313 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 4,200 | -- | (34,014) | (34,238) | (15,484) | (29,036) | |
| 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/12 HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | |
| Net Finance Costs / (Income) | 1,126 | -- | 2,380 | 2,479 | 3,391 | 3,931 |
| Depreciation & Amortisation | 4,657 | 4.722% | 8,572 | 7,979 | 9,076 | 9,529 |
| Directors' Emoluments | -- | -- | 1,051 | 1,049 | 1,094 | 5,639 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | 1.050 | -- | -8.520 | -8.580 | -3.880 | -7.280 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 0.024 | 0.027 | 0.013 | (0.076) |
| NBV per share ($) | 0.411 | -- | 0.404 | 0.488 | 0.577 | 0.562 |
| Remarks: | Real time quote last updated: 11/09/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD 4,200 |
| %Change | -- |
| EPS / (LPS) | HKD 0.011 |
| NBV Per Share ($) | HKD 0.411 |